Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromesLudwig Kappos, Rupert Sandbrink, Xavier Montalbán et al.|Neurology|2006Cited by 677
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trialGıancarlo Comı, Massimo Filippi, Vittorio Martinelli et al.|The Lancet|2009Cited by 587
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromesLudwig Kappos, Rupert Sandbrink, Chris H. Polman et al.|American Journal of Ophthalmology|2006Cited by 551